The WACC of Travere Therapeutics Inc (TVTX) is 7.8%.
| Range | Selected | |
| Cost of equity | 6.90% - 9.90% | 8.40% |
| Tax rate | 0.10% - 0.10% | 0.10% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 6.3% - 9.3% | 7.8% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.67 | 0.91 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.90% | 9.90% |
| Tax rate | 0.10% | 0.10% |
| Debt/Equity ratio | 0.29 | 0.29 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 6.3% | 9.3% |
| Selected WACC | 7.8% | |